Boehringer Ingelheim to build €200M veterinary vaccine plant in Lyon, France

Boehringer Ingelheim will invest more than €200 million to establish a new strategic production center for Veterinary Public Health in Lyon, France. The facility will produce foot-and-mouth disease and Bluetongue virus vaccines, creating approximately 100 jobs, and is expected to be operational by the end of 2021.

“This is a record investment into our production network.”biospace.com

• 1 source
• biospace.comBoehringer Ingelheim Invests More Than €200 Million to Establish Strategic Production Center for Veterinary Public Health in France - BioSpaceHeather McKenzieJul 10, 2018

Summarized from public sources; check the original articles before acting on it.